Abstract
The study was to investigate the ability of the contrast pulse sequencing technology (CPS) and SonoVueTM (a new contrast agent) to delineate placental angioarchitecture and observe whether the time-intensity curves would reflect the feature of vascular perfusion in placental central arterial canal and intervillous space.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
